Miwa Kuwahara
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Miwa Kuwahara has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Atsuo Ueda
Department of Clinical Laboratory, Tsukuba Medical Center Hospital, 1-3-1 Amakubo, Tsukuba, Ibaraki, 305-8558, Japan
3 shared publications - Daisuke Kato
Denka Co., Ltd. Gosen Site, Research & Development Division, Reagent R&D Department, 1-2-2 Minami-hon-cho, Gosen-shi, Niigata, 959-1695, Japan
3 shared publications - Hiromichi Suzuki
Department of Infectious Diseases, University of Tsukuba Hospital, Tsukuba, Japan
3 shared publications - Koji Nakamura
Department of Clinical Laboratory, Tsukuba Medical Center Hospital, 1-3-1 Amakubo, Tsukuba, Ibaraki, 305-8558, Japan
3 shared publications - Shigeyuki Notake
Department of Clinical Laboratory, Tsukuba Medical Center Hospital, 1-3-1 Amakubo, Tsukuba, Ibaraki, 3058558, Japan
3 shared publications - Shino Muramatsu
Denka Co., Ltd. Gosen Site, Research & Development Division, Reagent R&D Department, 1-2-2 Minami-hon-cho, Gosen-shi, Niigata, 959-1695, Japan
3 shared publications
Latest Publications
- Open Access
- 20 November 2022
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 29 (3) , 257-262
Analytical performance of the rapid qualitative antigen kit for the detection of SARS-CoV-2 during widespread circulation of the Omicron variant
- 20 November 2022
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 29 (3) , 257-262
Open AccessAnalytical performance of the rapid qualitative antigen kit for the detection of SARS-CoV-2 during widespread circulation of the Omicron variant
- 10 November 2021
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 28 (2) , 248-251
Evaluation and clinical implications of the time to a positive results of antigen testing for SARS-CoV-2
- 10 November 2021
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 28 (2) , 248-251
Evaluation and clinical implications of the time to a positive results of antigen testing for SARS-CoV-2
- Open Access
- 1 June 2021
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 27 (6) , 890-894
The evaluation of a newly developed antigen test (QuickNavi™-COVID19 Ag) for SARS-CoV-2: A prospective observational study in Japan
- 1 June 2021
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 27 (6) , 890-894
Open AccessThe evaluation of a newly developed antigen test (QuickNavi™-COVID19 Ag) for SARS-CoV-2: A prospective observational study in Japan